Race disparities in Wilms tumor incidence and biology.

Department of Pediatric Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Journal of Surgical Research (Impact Factor: 2.12). 03/2011; 170(1):112-9. DOI: 10.1016/j.jss.2011.03.011
Source: PubMed

ABSTRACT Wilms tumor (WT) is thought to arise in children of Black African ancestry with greater frequency than in Whites. To clarify the biological basis for race disparities in WT, we first verified that Black children residing in Tennessee have an increased incidence of WT, and second, established molecular profiles in WT that are specific to race.
To assess race disparities in WT epidemiology, the Tennessee Cancer Registry (TCR) was queried for all in-state patients less than 20 y of age and registered between 1999 and 2008. To explore race disparities in WT biology, six Black and four White WT specimens acquired in Tennessee were analyzed using imaging mass spectrometry (IMS).
TCR data show that Black children are over-represented among WT patients (29%) relative to all other childhood cancers (18.5%; P = 0.01). WT ranked the fifth most common cancer diagnosis among Blacks, but ninth among Whites. The diagnosis of WT occurred 79% more frequently among Blacks (n = 28) than Whites (n = 69; P = 0.01), and proportionally more Blacks tended to present with distant disease. Although overall survival from WT was not statistically different between Blacks (92.9%) and Whites (94.0%), Black males showed the lowest survival (85%; P = 0.21). IMS analysis identified peptide spectra from both WT blastema and stroma that independently classify specimens according to race with greater than 80% accuracy.
In Tennessee, Black children appear more susceptible than Whites to develop WT. Race-specific molecular profiles can be determined that may help to clarify pathways of Wilms tumorigenesis and the biological basis for race disparities in WT incidence and biology.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To determine the outcome of patients with nephroblastoma in a South African hospital. To determine if there is a difference in the outcome of patients with nephroblastoma comparing two treatment protocols SIOP (Société International D'Oncologie Pédiatrique Protocol) versus NWTS (National Wilms' Tumour Study Protocol). A retrospective audit of 25 years (1983-2007), of children diagnosed with nephroblastoma in Tygerberg Hospital. One hundred and seven patients were included in the study and 98 were analyzed. The average age at diagnosis was 3.8 years. Most patients (37%) presented with stage 1 of the disease, followed by patients with stage 3 (27%). Most patients were treated according to the SIOP protocol (61%). Gender and race did not influence the outcome. Patients with stage 1 and 2 of the disease had the best outcome (76% versus 43% for stages 3 and 4). The SIOP group had a better outcome than the NWTS group (p value 0.001). The two groups had an equal distribution of the stage of presentation. The tumor volumes were bigger in the NWTS group (1004cm3 compared to 613cm3). Nutritional status did not influence the outcome although more patients were underweight for age in the SIOP group. The statistical methods used were: Kaplan Meier, Gehan's Wilcoxon Test, Chi -square test and the Fisher exact test. Contrary to the other studies, patients treated according to the SIOP protocol had a statistically significant better outcome. Larger collaborative studies are needed to investigate this result in Africa. SIOP = Société International D'Oncologie Pédiatrique Protocol, NWTS = National Wilms' Tumor Study Protocol.
    Journal of medicine and life 09/2014; 7(3):445-9.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Wilms tumor (WT) is the most common childhood kidney cancer worldwide and arises in children of black African ancestry with greater frequency and severity than other race groups. A biologic basis for this pediatric cancer disparity has not been previously determined. We hypothesized that unique molecular fingerprints might underlie the variable incidence and distinct disease characteristics of WT observed between race groups. To evaluate molecular disparities between WTs of different race groups, the Children's Oncology Group provided 80 favorable histology specimens divided evenly between black and white patients and matched for disease characteristics. As a surrogate of black sub-Saharan African patients, we also analyzed 18 Kenyan WT specimens. Tissues were probed for peptide profiles using matrix-assisted laser desorption ionization time of flight imaging mass spectrometry. To control for histologic variability within and between specimens, cellular regions were analyzed separately as triphasic (containing blastema, epithelia, and stroma), blastema only, and stroma only. Data were queried using ClinProTools and statistically analyzed. Peptide profiles, detected in triphasic WT regions, recognized race with good accuracy, which increased for blastema- or stroma-only regions. Peptide profiles from North American WTs differed between black and white race groups but were far more similar in composition than Kenyan specimens. Individual peptides were identified that also associated with WT patient and disease characteristics (eg, treatment failure and stage). Statistically significant peptide fragments were used to sequence proteins, revealing specific cellular signaling pathways and candidate drug targets. Wilms tumor specimens arising among different race groups show unique molecular fingerprints that could explain disparate incidences and biologic behavior and that could reveal novel therapeutic targets.
    Journal of the American College of Surgeons 04/2014; 218(4):707-20. DOI:10.1016/j.jamcollsurg.2013.12.044 · 4.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Wilms tumor (WT) is the most common renal malignancy of childhood. Our aim was to verify the epidemiological profile and prognosis of a sample of patients from Brazil and compare them to similar data especially presented in studies developed in Latin America. The sample consisted of consecutive patients diagnosed with WT in an onco-hematology service of a referral hospital in Southern Brazil, in the period between 1989 and 2009. Clinical, radiological, pathological and survival data were collected from the medical records. The analysis was performed using Excel program and SPSS version 18.0. The significance level was of P<0.05. Our final sample consisted of 45 patients. The male/female ratio was 1.25:1. The mean age at diagnosis was 43.9 months and all patients were Euro-descendants. Thirty three patients (73.3%) presented both signs/symptoms of abdominal mass and hypertension. Malformations were observed in 9 patients (20%). There was a case of Fanconi's anemia (2.2%). Three cases were bilateral (6.7%). The majority of patients had stage III and IV (62.2%). We found that patients with malformations had an earlier age at diagnosis (P= 0.018) and more bilateral disease (P= 0.044). The overall survival was 75%. Age at diagnosis was the only significant independent predictor associated to death. We believe that our deaths are closely related to late diagnosis. Oncologic services should also be concerned about the morbidities caused by therapeutical options in these late diagnosed cases and its consequences in the quality of life of the patients.
    Pediatrics International 01/2014; 56(4). DOI:10.1111/ped.12295 · 0.73 Impact Factor


1 Download
Available from